Trivarx Ltd (tri) Logo

Trivarx Ltd (TRI)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials

TRI ASX Chart

Snapshot

Medibio Limited (MEB, formerly BioProspect Limited) is a medical technology company that conducts clinical research, product development and early stage commercialization of a mental health technology using objective biomarkers to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) +25.51%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,863 of 2,384
Sector Rank 179 of 226

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies ESE / HIQ / ZLD
EPS -$0.02
DPS $0.00
Book Value Per Share -$0.004

Broker Consensus

TRI is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Top Market Index News

More News

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Mount Lawley WA 6050
Website www.medibio.com.au
Registry Automic Group
Auditor William Buck (QLD)
Date Listed 29 Jan 2001

Upcoming Calendar (Forecasted)

Date Event
29/08/2024 Report (Prelim)
27/09/2024 Report (Annual)
26/02/2025 Report (Interim)

Former Company Names

  • Medibio Limited (MEB), 13/10/2023
  • Bioprospect Limited (BPO), 28/11/2014

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

TRI directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
13/10/23 David Trimboli Issued 35,750,000 $0.001 $25,138 Issue of options
13/10/23 David Trimboli Issued 50,000,000 $0.001 $50,000 Placement
13/10/23 David Trimboli Issued 95,194,513 $0.001 $142,791 Director remuneration
13/10/23 Christopher Ntoumenopoulos Issued 47,250,000 $0.000 $19,552 Issue of options
13/10/23 Christopher Ntoumenopoulos Issued 18,589,746 $0.001 $27,884 Director remuneration
22/06/23 David Trimboli Issued 83,333,333 $0.001 $83,333 Participation in share purchase plan
22/06/23 Christopher Ntoumenopoulos Issued 66,666,667 $0.001 $100,000 Participation in share purchase plan
22/06/23 Christopher Ntoumenopoulos Issued 33,333,333 $0.001 $33,333 Participation in share purchase plan

Director Interests

The current holdings of TRI directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
David Trimboli 13/10/2023 0 261,861,180 169,083,333 N/A
Christopher Ntoumenopoulos 13/10/2023 0 85,256,413 80,583,333 N/A
Thomas Young 12/04/2023 0 N/A N/A N/A
Melanie Leydin 12/04/2023 0 N/A 4,800,000 N/A
Silvio Salom N/A N/A N/A N/A N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Sep 5, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Hsbc Custody Nominees (Australia) Limited 38,486,111 7.32%
Dragan Inv Pty Ltd <Dn Super Fund A/C> 32,000,000 6.09%
Ms Sihol Marito Gultom 31,000,000 5.90%
Sunset Capital Management Pty Ltd <Sunset Superfund A/C> 29,000,000 5.52%
Rookharp Capital Pty Limited 24,775,167 4.71%
Mr John Yacoub 22,500,000 4.28%
Mr Brent Joseph Evitt <B&J Be Fund A/C> 18,709,585 3.56%
Mr Anthony Dell'Aquila 16,000,000 3.04%
Mr Peter Andrew Proksa 14,000,000 2.66%
Mercury Anetac Capital Pty Ltd 11,635,175 2.21%
Mr Kevin Trevor Wyatt 10,250,000 1.95%
First Investment Partners Pty Ltd 10,000,000 1.90%
Mr Ryan James Rowe 10,000,000 1.90%
Mr Samuel Gershon Jacobs and Mrs Sarita Devi Jacobs and Miss Manekha Bridgette Jacobs 10,000,000 1.90%
Venus Anetac Pty Ltd <RGC Family A/C> 8,325,082 1.58%
Dragan Group Pty Ltd 8,000,000 1.52%
CPS Capital No 5 Pty Ltd 6,750,738 1.28%
Wlp Investments Pty Ltd 6,682,222 1.27%
Mrs Yan Wang <Aust West Coast Travel A/C> 6,444,445 1.23%
Mr Warren George Lamberth 6,179,851 1.18%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 262 396 157 750 677 2,242

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
FIL Limited and the entities 13/10/2023 656,184,415 9.77

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
13-10-23 FIL Limited and the entities 149,850,000 8.30 9.77
16-08-23 FIL Limited and the entities 91,690,095 9.99 8.30

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
TRI Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.